A ‘war on children': as US changes Covid vaccine rules, parents of trial volunteers push back
As the Trump administration contemplates new clinical trials for Covid boosters and moves to restrict Covid vaccines for children and others, parents whose children participated in the clinical trials expressed anger and dismay.
'It's really devastating to see this evidence base officially ignored and discarded,' said Sophia Bessias, a parent in North Carolina whose two- and four-year-old kids were part of the Pfizer pediatric vaccine trial.
'It's infuriating. My kids contributed literal blood and tears to help demonstrate the safety of these vaccines,' Bessias said.
Related: Doctors fear 'devastating consequences' for pregnant people after RFK Jr order on Covid-19 boosters
'As a parent and also a pediatrician, I think it's devastating that we might no longer have the option to protect kids against Covid,' said Katherine Matthias, a pediatrician in South Carolina and a cofounder of Protect Their Future, a children's health organization.
Robert F Kennedy Jr, head of the US Department of Health and Human Services (HHS), has called for new trials using saline placebos for each of the routine childhood vaccines recommended by the Centers of Disease Control and Prevention (CDC), even though these vaccines have already been tested against placebos or against vaccines that were themselves tested against placebos.
Marty Makary, the head of the US Food and Drug Administration (FDA), and Vinay Prasad, the FDA's vaccines chief, outlined a plan in a recent editorial to restrict Covid boosters for anyone under the age of 65 without certain health conditions.
For everyone else between the ages of six months and 64 years old, each updated Covid vaccine would need to undergo another randomized controlled clinical trial, Makary and Prasad said.
It's not clear when, how or whether this plan will be implemented officially.
On Tuesday, top US health officials said on the social media site X that they would remove the recommendation for Covid vaccination from the childhood immunization schedule, and would also cease recommending it for pregnant people, who have much higher risks of illness, death and pregnancy complications with Covid.
On Friday, the CDC appeared to contradict that announcement by keeping Covid vaccines as a routine immunization for children – though the agency now says health providers 'may' recommend the vaccine, instead of saying they 'should' recommend it.
Changing recommendations could affect doctors' and parents' understanding of the safety and effectiveness of the vaccines.
Vaccines recommended by the CDC are also covered by the federal Vaccines for Children program, and health insurers are required to cover the costs of routine vaccines. It's not clear if the wording change from 'should' to 'may' will affect that coverage.
If insurance no longer covers the vaccines, pediatricians are less likely to keep many of the shots in stock, Matthias said, and pharmacies are limited by different state laws on which ages they may vaccinate – which means families who want the vaccines may not be able to find them.
Matthias drove her children, then aged 15 months and 14 years old, two hours each way to a Moderna pediatric trial. They did six or seven visits, plus two visits to receive the actual vaccines after they learned they had received placebos.
Child participants spent hours on each visit and endured blood draws, Covid swabs, regular symptom and temperature monitoring, and, of course, several shots. Each shot was followed by a week of daily journaling and side-effect reporting.
Participants who got Covid, even months later, had blood draws to check their antibody responses.
'It was a pretty big commitment of our time and energy. But I did it because I wanted to be sure that my kids and all kids had access to vaccines,' Matthias said.
Laura Labarre, a parent in Oregon, said the trials involved 'committing to something that felt important but larger than ourselves, because it ended up being a lot of work and a lot of logistics and a lot of effort'.
She drove her two kids, then aged one and three, an hour and a half each way to a Pfizer trial, and searched for ways to keep them occupied for hours on end.
When most people hear about new developments in pediatric medicine, such as new vaccines, they don't often consider the hard work of volunteers, some only a few months old, who made the trials possible, Labarre said.
'I don't think people consider the toll on the families who are the ones who bravely and nervously put their children up to be the first to try it out,' she said.
When Nick Giglia got the call asking if he still wanted to enroll his one-year-old daughter in the Pfizer pediatric vaccine trial, he immediately said yes.
For eight visits, extending over nearly a year, he would drive an hour each way to a trial in New Jersey. In all, his daughter received seven shots – three saline placebos, three vaccines and a booster.
'It was very rigorous,' Giglia said of the study design.
Now, he said, 'it's really difficult to hear people harping on the thoughts of there not being the placebo group. Well, it's news to me. My kid was in the placebo group,' he said.
Parents who were eager to enroll in the original trials now wonder whether families would want to endure another round of placebo-controlled trials for updated vaccines.
'Finding the number of participants that they would need would be extremely difficult,' Matthias said.
'To think that they would subject anyone, let alone children, to potentially getting the placebo in a trial where we know that the control is already so beneficial for health, just seems highly unethical and really disturbing,' Labarre said.
'A new trial today would not add anything we don't already know,' Bessias said. 'It would feel like actually participating in a project of undermining the existing evidence, rather than contributing new evidence.'
And the whole point of updating the vaccines is to counter new strains, Matthias said. Those vaccines would be out of date by the conclusion of a new study, which could take years.
'People should have the option' to get Covid vaccines, Matthias said. 'The people who don't want it don't have to get it.'
When Matthias enrolled her kids in 2021, she felt as though they were in a limbo, and 'we were all just desperate to get our kids protected', she said. 'To kind of have that feeling coming back now – we worked so hard and we advocated so much to get our kids access and now it might just be taken away – is really upsetting.'
While Covid mortality rates are highest among people over the age of 65, Covid is still the eighth leading cause of all deaths among children.
Any child dying a preventable death is a tragedy, Bessias said.
'We have to take a step back and realize that absolute numbers matter, too. And we can really avoid a lot of hospitalizations and deaths and transmission and horrible experiences for families by reaching those younger children. It's baffling because that seems to be completely left out of these discussions.'
Labarre feels 'profoundly enraged and betrayed' by the Trump administration's actions. Limiting access to the vaccine, especially while proposing cuts to Snap and Medicaid, feels like 'an additional audacious battlefront they've opened up in this sort of war on children', she said.
'It is destabilizing, frustrating and enraging to feel like my daughter, who wasn't even 18 months old, has done more for public health than some people who are now currently in charge of it,' Giglia said.
'It is very frustrating to hear that sacrifice that we volunteered to make for the country, and frankly, the world, belittled.'
At the end of the trial, Giglia's daughter was given a stuffed teddy bear in a sweater that said 'Covid-19 vaccine study hero'.
'I don't care what anybody says. That's what she is,' Giglia said. 'I look forward to one day being able to tell my little girl all about how she helped save the world. And it's hard to hear that many people think that we did the exact opposite.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
40 minutes ago
- Medscape
DASH4D Diet for BP Control in T2D: Less Salt, Better Results
In adults with type 2 diabetes (T2D) on multiple antihypertensive medications, a modified Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet combined with reduced sodium intake led to a clinically relevant reduction in systolic blood pressure (BP), with the benefits primarily attributed to sodium reduction. METHODOLOGY: Although the original DASH diet — rich in fruits, vegetables, and low-fat dairy products and low in saturated fat and cholesterol — is recommended with sodium reduction for managing hypertension in patients with T2D, evidence of its effectiveness in this population remains limited. Researchers conducted a single-site study in Maryland to assess the efficacy of the DASH4D diet, featuring lower carbohydrates, higher unsaturated fats, and lower potassium than the original DASH diet, together with reduced dietary sodium for BP management in T2D. They included 102 adults with T2D (mean age, 66 years; 66% women) between June 2021 and December 2023; the patients had a mean baseline BP of 135/75 mm Hg; 66% of them used at least two antihypertensive medicines, and 55% used two or more glucose-lowering medicines. Participants were randomly assigned to be provided with four diets in sequence, each for 5 weeks: The DASH4D diet with lower sodium, DASH4D diet with higher sodium, typical US diet with lower sodium, and typical US diet with higher sodium; in a 2000-kcal menu, the lower and higher sodium levels were set at 1500 mg/d and 3700 mg/d, respectively. The primary outcome was end-of-period systolic BP, measured on 5 separate days during the last 2 weeks of each feeding period. TAKEAWAY: Compared with patients on the typical US diet with higher sodium, those who received the DASH4D diet with lower sodium showed an average systolic BP reduction of 4.6 mm Hg (95% CI, -7.2 to -2.0) and an average diastolic BP reduction of 2.3 mm Hg (95% CI, -3.7 to -0.9) after 5 weeks. Among patients on the DASH4D diet, systolic BP was reduced by 4.8 mm Hg (95% CI, -7.4 to -2.2) in those with lower vs higher dietary sodium. Most reductions in BP occurred during the first 3 weeks of each diet period. Patients completely adhered to the recommended diet for 96% of the study days. The frequency of adverse events was low. IN PRACTICE: '[The findings] provide evidence of the efficacy of BP lowering through dietary change in people with T2D, including those treated with multiple antihypertensive and glucose-lowering medications,' the authors of the study wrote. 'High adherence to the DASH4D lower sodium diet suggests that the diet is acceptable.' SOURCE: This study was led by Scott J. Pilla, MD, MHS, Johns Hopkins University School of Medicine in Baltimore. It was published online on June 9, 2025, in JAMA Internal Medicine . LIMITATIONS: This study was not powered sufficiently to detect individual effects of the DASH4D diet and sodium reduction. As a single-center study, the study population lacked diversity. Participant feeding was disrupted at multiple points owing to the COVID-19 pandemic. DISCLOSURES: This study received funding from the Sheikh Khalifa Stroke Institute at Johns Hopkins University School of Medicine, grants from National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute grant, and the National Center for Advancing Translational Science Awards Program. Several authors reported receiving grants from sources including the funding agency and National Institutes of Health. Some authors reported serving on the scientific advisory board or receiving personal fees outside the submitted work.


Associated Press
40 minutes ago
- Associated Press
Pager Health (SM) Launches Industry's First End-to-End Member Navigation Platform
Pager Health Navigator redefines the member experience by connecting provider, clinical, benefits, and program navigation in one seamless, AI-powered solution NEW YORK, June 16, 2025 /PRNewswire/ -- Pager Health, a connected health platform company serving more than 26 million members in the United States and Latin America, today announced the launch of Pager Health Navigator, a seamless, scalable, AI-powered care navigation system that radically transforms the health plan member experience. Pager Health Navigator is the first navigation solution to integrate four previously disconnected member services—provider, clinical, benefits, and program navigation—into one connected platform available through a single interface. By empowering members to steer their care with confidence, unmatched speed and convenience, Navigator seeks to elevate consumers' perception of health plans, establishing them as a trusted partner and central access point for their health journey. 'With the launch of Pager Health Navigator, the days of siloed and fragmented healthcare experiences that confuse members, delay care, and drive up costs are over,' said Walter Jin, Chairman and CEO of Pager Health. 'Navigator is more than an innovation; it's the arrival of a new standard in connected care. It unifies clinical, provider, solution, and benefits navigation to empower member engagement, replacing confusion with clarity and transforming a maze of disconnected touchpoints into a connected healthcare experience. Health plans can now finally deliver the seamless, personalized experience their members expect when using any other digital connection, while improving engagement, streamlining support, redirecting care to appropriate settings, and ultimately achieving meaningful ROI.' Four Powerful Navigation Tools, One Seamless Experience Pager Health Navigator's four core services use AI-powered features and other advanced capabilities to streamline care access, personalize member experiences, and reduce friction across the healthcare journey. In addition to unifying member navigation, Navigator leverages AI-powered personalized guidance throughout the entire member experience, from triage and benefits clarification to FAQs and next-best actions, with nurse-led support always available. Proactive outreach includes automated campaigns, targeted messages, and timely reminders for wellness visits and health assessments. Omnichannel member engagement across all major touchpoints, including SMS, app, portal, phone, secure chat, WhatsApp, and email, maximizes reach and responsiveness. Purpose-Built to Work Within Health Plans Specifically engineered to integrate with a health plan's existing technology stack and service operations, Navigator delivers a white-labeled experience that gives full credit to the health plan for facilitating the member experience. 'AI is rewriting the rules on how people connect with products and services, and healthcare is not immune to this revolution,' Jin said. 'It is now a market imperative for health plans to embrace AI innovation in member engagement and care coordination or risk irrelevance. Pager Health Navigator presents a pivotal opportunity for health plans to lead this transformation toward truly member-centered care.' With Navigator, Pager Health is advancing its mission to transform healthcare through smarter, more connected member experiences. This launch reinforces Pager's commitment to helping health plans generate seamless navigation, reduce costs, improve satisfaction, and deliver measurable value. For more information about Pager Health, please visit About Pager Health Pager Health is a connected health platform company that enables healthcare enterprises to deliver high-engagement, intelligent health experiences across wellness, care navigation, and care management engagement. Through integrated technology, AI, and concierge services, our platform helps patients and members get the right care at the right time in the right place and stay healthy. By reducing system friction and fragmentation, powering engagement, and orchestrating the enterprise, Pager Health drives better outcomes at scale. We partner with leading payers, providers, and employers, representing more than 26 million individuals across the United States and Latin America. Media Contact Pager Health Christopher Gale [email protected] View original content: SOURCE Pager Health

Associated Press
40 minutes ago
- Associated Press
Dr. Ashley Capps Unveils Premium Autoimmune Rebalance System: A Groundbreaking Approach to Autoimmune Recovery Through Trauma-Informed Healing
Dr. Ashley Capps announces the launch of her Autoimmune Rebalance System, offering a premium, trauma-informed healing approach for women to address autoimmune symptoms at their root causes. United States, June 16, 2025 -- Dr. Ashley Capps Introduces a Revolutionary Autoimmune Recovery System Focused on Trauma and Stress In an unconventional move that is redefining autoimmune disease recovery, Dr. Ashley Capps, a behavioral health doctor and licensed mental health therapist, has launched the Autoimmune Rebalance System. This premium, trauma-informed program is designed specifically to help women tackle the root causes of autoimmune diseases by focusing on the often-overlooked contributors of chronic stress, unresolved trauma, and nervous system dysregulation. Dr. Capps' approach challenges the traditional medical model, which often isolates the physical and mental aspects of health. By incorporating modern psychoneuroimmunology research, Dr. Capps provides a comprehensive, holistic framework for autoimmune recovery. This innovative program emphasizes the mind-body connection as a central pillar of healing, offering a more sustainable and integrated solution for those suffering from autoimmune conditions. The Trauma-Informed Approach to Autoimmune Recovery Unlike conventional programs that primarily focus on symptom management through diet, medications, or supplements, Dr. Capps' Autoimmune Rebalance System integrates trauma recovery at its core. By addressing the mental, emotional, and neurological influences on immune system function, Dr. Capps offers a comprehensive healing process that goes far beyond symptom suppression. 'Chronic stress and unresolved trauma have been shown to trigger immune dysfunction, and for many women, this often goes unaddressed in traditional medical care,' says Dr. Capps. 'We need to approach autoimmune disease recovery with a full understanding of how trauma impacts the body. It's not enough to simply treat the symptoms—we need to focus on healing the underlying emotional and psychological triggers that fuel autoimmune flare-ups.' The Autoimmune Rebalance System provides participants with the tools to regulate their nervous system, heal from past trauma, and manage the chronic stress that often leads to autoimmune dysfunction. This integrated approach empowers individuals to break free from the cycle of symptom management and instead focus on lasting recovery. How the Autoimmune Rebalance System Works: A Comprehensive and Compassionate Framework The Autoimmune Rebalance System is grounded in the principles of psychoneuroimmunology, which studies the relationship between the nervous system, immune system, and endocrine system. This premium program combines cutting-edge science with compassionate behavioral health practices to rewire how women relate to their bodies, health, and healing processes. Dr. Capps has spent over a decade refining this trauma-informed approach, and it is tailored specifically to address the unique challenges women face. Medical gaslighting, emotional labor, and identity shifts are common issues for women navigating autoimmune disease, and Dr. Capps has integrated these realities into the system's design. Rather than encouraging individuals to 'push through' their symptoms, Dr. Capps' program fosters a deeper connection to the body's natural healing mechanisms, focusing on nervous system regulation, emotional resilience, and real-time integration of recovery practices into daily life. The result is a personalized approach that prioritizes sustainable healing through compassionate, non-judgmental care. A New Standard for Women's Autoimmune Recovery The Autoimmune Rebalance System stands apart by offering a level of personalization and flexibility not often found in other programs. While many traditional systems rely on rigid regimens, Dr. Capps' program emphasizes flexible frameworks and compassionate consistency. The focus is on progress and healing, not perfection. Participants are encouraged to adapt to their own unique needs and experiences—whether navigating energy shifts, managing flare-ups, or addressing emotional waves—while building sustainable recovery practices. The system does not prescribe a one-size-fits-all solution, but rather empowers women to listen to their bodies and engage in a healing process that fits their individual circumstances. This tailored approach, grounded in a deep understanding of both the clinical and emotional aspects of autoimmune disease, positions Dr. Capps' Autoimmune Rebalance System as a premier resource for women seeking to take control of their health and well-being. A Personal Journey to Empowerment and Healing Dr. Ashley Capps is not only a recognized expert in the field of autoimmune recovery but also a passionate advocate for trauma-informed care. Her personal commitment to this work is rooted in a deep understanding of the complex intersection between trauma, stress, and autoimmune disease. Having worked with hundreds of women in clinical settings, Dr. Capps has seen firsthand how untreated emotional and psychological trauma can exacerbate autoimmune conditions. Her ability to blend clinical rigor with an intuitive, compassionate approach has made her a sought-after speaker and educator in the fields of women's health, chronic illness recovery, and trauma. Her unique qualifications allow her to guide women through a healing process that combines the latest science with practical, real-life tools. As Dr. Capps continues to expand the reach of her Autoimmune Rebalance System, she remains dedicated to reshaping the conversation about autoimmune disease. She firmly believes that true healing comes from addressing both the mind and body, and this system represents her commitment to helping women reclaim their health through holistic, trauma-informed care. About Dr. Ashley Capps and the Autoimmune Rebalance System Dr. Ashley Capps is a behavioral health doctor, licensed mental health therapist, and the founder of the Autoimmune Rebalance System. She has over a decade of clinical experience in trauma recovery, psychoneuroimmunology, and integrative behavioral health. Dr. Capps' innovative program blends cutting-edge research with compassionate care to help women heal from autoimmune diseases by addressing the root causes of chronic stress and trauma. Her system has been designed to provide a holistic and sustainable recovery experience, empowering women to take control of their health through personalized, trauma-informed healing practices. Media Contact: Dr. Ashley Capps Phone: 850-527-5488 Email: [email protected] Contact Info: Name: Dr. Ashley Capps Email: Send Email Organization: The Autoimmune Rebalance System Website: Release ID: 89162375 In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.